1.	Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) Phase: Phase II Type: Diagnostic Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: LSU #6169, NCT00784849
2.	Axillary Reverse Mapping Phase: Phase II Type: Diagnostic Status: Closed Age: 18 to 100 Sponsor: Other Protocol IDs: 11737, NCT01381315
3.	Phase I Study of Methylene Blue for the Treatment of Hypotension in Patients with Advanced Cancer Receiving IL-1A Support for CBDCA Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: BRMP-9211, NCI-T92-0216N, T92-0216
4.	Diagnostic Study of Lymphatic Mapping and Sentinel Node Identification in Patients With Stage IB1 Cervical Cancer Phase: No phase specified Type: Diagnostic, Treatment Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: GOG-0206, NCT00070317
5.	Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: 3157, NCT00314405